Birks J

References (14)

Title : Galantamine for vascular cognitive impairment - Birks_2013_Cochrane.Database.Syst.Rev_4_CD004746
Author(s) : Birks J , Craig D
Ref : Cochrane Database Syst Rev , 4 :CD004746 , 2013
Abstract : Birks_2013_Cochrane.Database.Syst.Rev_4_CD004746
ESTHER : Birks_2013_Cochrane.Database.Syst.Rev_4_CD004746
PubMedSearch : Birks_2013_Cochrane.Database.Syst.Rev_4_CD004746
PubMedID: 23862185

Title : Rivastigmine for vascular cognitive impairment - Birks_2013_Cochrane.Database.Syst.Rev_5_CD004744
Author(s) : Birks J , McGuinness B , Craig D
Ref : Cochrane Database Syst Rev , 5 :CD004744 , 2013
Abstract : Birks_2013_Cochrane.Database.Syst.Rev_5_CD004744
ESTHER : Birks_2013_Cochrane.Database.Syst.Rev_5_CD004744
PubMedSearch : Birks_2013_Cochrane.Database.Syst.Rev_5_CD004744
PubMedID: 23728651

Title : For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not? -
Author(s) : Ames D , Kaduszkiewicz H , van den Bussche H , Zimmermann T , Birks J , Ashby D
Ref : Int Psychogeriatr , 20 :259 , 2008
PubMedID: 18252031

Title : Investigational treatment for vascular cognitive impairment - Birks_2007_Expert.Opin.Investig.Drugs_16_647
Author(s) : Birks J , Flicker L
Ref : Expert Opin Investig Drugs , 16 :647 , 2007
Abstract : Birks_2007_Expert.Opin.Investig.Drugs_16_647
ESTHER : Birks_2007_Expert.Opin.Investig.Drugs_16_647
PubMedSearch : Birks_2007_Expert.Opin.Investig.Drugs_16_647
PubMedID: 17461738

Title : Cholinesterase inhibitors for Alzheimer's disease - Birks_2006_Cochrane.Database.Syst.Rev__CD005593
Author(s) : Birks J
Ref : Cochrane Database Syst Rev , :CD005593 , 2006
Abstract : Birks_2006_Cochrane.Database.Syst.Rev__CD005593
ESTHER : Birks_2006_Cochrane.Database.Syst.Rev__CD005593
PubMedSearch : Birks_2006_Cochrane.Database.Syst.Rev__CD005593
PubMedID: 16437532

Title : Donepezil for dementia due to Alzheimer's disease - Birks_2006_Cochrane.Database.Syst.Rev__CD001190
Author(s) : Birks J , Harvey RJ
Ref : Cochrane Database Syst Rev , :CD001190 , 2006
Abstract : Birks_2006_Cochrane.Database.Syst.Rev__CD001190
ESTHER : Birks_2006_Cochrane.Database.Syst.Rev__CD001190
PubMedSearch : Birks_2006_Cochrane.Database.Syst.Rev__CD001190
PubMedID: 16437430

Title : Donepezil for mild cognitive impairment - Birks_2006_Cochrane.Database.Syst.Rev_3_CD006104
Author(s) : Birks J , Flicker L
Ref : Cochrane Database Syst Rev , 3 :CD006104 , 2006
Abstract : Birks_2006_Cochrane.Database.Syst.Rev_3_CD006104
ESTHER : Birks_2006_Cochrane.Database.Syst.Rev_3_CD006104
PubMedSearch : Birks_2006_Cochrane.Database.Syst.Rev_3_CD006104
PubMedID: 16856114

Title : Galantamine for vascular cognitive impairment - Craig_2006_Cochrane.Database.Syst.Rev__CD004746
Author(s) : Craig D , Birks J
Ref : Cochrane Database Syst Rev , :CD004746 , 2006
Abstract : Craig_2006_Cochrane.Database.Syst.Rev__CD004746
ESTHER : Craig_2006_Cochrane.Database.Syst.Rev__CD004746
PubMedSearch : Craig_2006_Cochrane.Database.Syst.Rev__CD004746
PubMedID: 16437493

Title : Rivastigmine for vascular cognitive impairment - Craig_2005_Cochrane.Database.Syst.Rev__CD004744
Author(s) : Craig D , Birks J
Ref : Cochrane Database Syst Rev , :CD004744 , 2005
Abstract : Craig_2005_Cochrane.Database.Syst.Rev__CD004744
ESTHER : Craig_2005_Cochrane.Database.Syst.Rev__CD004744
PubMedSearch : Craig_2005_Cochrane.Database.Syst.Rev__CD004744
PubMedID: 15846730

Title : Donepezil for vascular cognitive impairment - Malouf_2004_Cochrane.Database.Syst.Rev__CD004395
Author(s) : Malouf R , Birks J
Ref : Cochrane Database Syst Rev , :CD004395 , 2004
Abstract : Malouf_2004_Cochrane.Database.Syst.Rev__CD004395
ESTHER : Malouf_2004_Cochrane.Database.Syst.Rev__CD004395
PubMedSearch : Malouf_2004_Cochrane.Database.Syst.Rev__CD004395
PubMedID: 14974068

Title : Evidence-based pharmacotherapy of Alzheimer's disease - Evans_2004_Int.J.Neuropsychopharmacol_7_351
Author(s) : Evans JG , Wilcock G , Birks J
Ref : Int J Neuropsychopharmacol , 7 :351 , 2004
Abstract : Evans_2004_Int.J.Neuropsychopharmacol_7_351
ESTHER : Evans_2004_Int.J.Neuropsychopharmacol_7_351
PubMedSearch : Evans_2004_Int.J.Neuropsychopharmacol_7_351
PubMedID: 15228642

Title : Velnacrine for Alzheimer's disease - Birks_2004_Cochrane.Database.Syst.Rev__CD004748
Author(s) : Birks J , Wilcock GG
Ref : Cochrane Database Syst Rev , :CD004748 , 2004
Abstract : Birks_2004_Cochrane.Database.Syst.Rev__CD004748
ESTHER : Birks_2004_Cochrane.Database.Syst.Rev__CD004748
PubMedSearch : Birks_2004_Cochrane.Database.Syst.Rev__CD004748
PubMedID: 15106259

Title : Physostigmine for Alzheimer's disease - Coelho_2001_Cochrane.Database.Syst.Rev__CD001499
Author(s) : Coelho F , Birks J
Ref : Cochrane Database Syst Rev , :CD001499 , 2001
Abstract : Coelho_2001_Cochrane.Database.Syst.Rev__CD001499
ESTHER : Coelho_2001_Cochrane.Database.Syst.Rev__CD001499
PubMedSearch : Coelho_2001_Cochrane.Database.Syst.Rev__CD001499
PubMedID: 11405996

Title : Rivastigmine for Alzheimer's disease - Birks_2000_Cochrane.Database.Syst.Rev__CD001191
Author(s) : Birks J , Iakovidou V , Tsolaki M
Ref : Cochrane Database Syst Rev , :CD001191 , 2000
Abstract : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
ESTHER : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
PubMedSearch : Birks_2000_Cochrane.Database.Syst.Rev__CD001191
PubMedID: 10796621